307 related articles for article (PubMed ID: 23021109)
1. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
[TBL] [Abstract][Full Text] [Related]
2. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
3. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.
Dalal S; Hui D; Bidaut L; Lem K; Del Fabbro E; Crane C; Reyes-Gibby CC; Bedi D; Bruera E
J Pain Symptom Manage; 2012 Aug; 44(2):181-91. PubMed ID: 22695045
[TBL] [Abstract][Full Text] [Related]
4. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
5. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer.
Sandini M; Bernasconi DP; Fior D; Molinelli M; Ippolito D; Nespoli L; Caccialanza R; Gianotti L
Nutrition; 2016; 32(11-12):1231-7. PubMed ID: 27261062
[TBL] [Abstract][Full Text] [Related]
6. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.
Cloyd JM; Nogueras-González GM; Prakash LR; Petzel MQB; Parker NH; Ngo-Huang AT; Fogelman D; Denbo JW; Garg N; Kim MP; Lee JE; Tzeng CD; Fleming JB; Katz MHG
J Gastrointest Surg; 2018 Apr; 22(4):703-712. PubMed ID: 29230694
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
8. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Prado CM; Sawyer MB; Ghosh S; Lieffers JR; Esfandiari N; Antoun S; Baracos VE
Am J Clin Nutr; 2013 Oct; 98(4):1012-9. PubMed ID: 23966429
[TBL] [Abstract][Full Text] [Related]
9. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia.
Han J; Tang M; Lu C; Shen L; She J; Wu G
Clin Nutr; 2021 Sep; 40(9):5156-5161. PubMed ID: 34461589
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease.
Shintakuya R; Uemura K; Murakami Y; Kondo N; Nakagawa N; Urabe K; Okano K; Awai K; Higaki T; Sueda T
Pancreatology; 2017; 17(1):70-75. PubMed ID: 27743711
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
13. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.
Kazemi-Bajestani SM; Mazurak VC; Baracos V
Semin Cell Dev Biol; 2016 Jun; 54():2-10. PubMed ID: 26343952
[TBL] [Abstract][Full Text] [Related]
15. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
16. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
17. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.
van Dijk DP; Bakens MJ; Coolsen MM; Rensen SS; van Dam RM; Bours MJ; Weijenberg MP; Dejong CH; Olde Damink SW
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):317-326. PubMed ID: 27897432
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of computerized tomography in assessing cancer cachexia.
Prado CM; Birdsell LA; Baracos VE
Curr Opin Support Palliat Care; 2009 Dec; 3(4):269-75. PubMed ID: 19667996
[TBL] [Abstract][Full Text] [Related]
19. Preoperative sarcopenia determinants in pancreatic cancer patients.
Carrara G; Pecorelli N; De Cobelli F; Cristel G; Damascelli A; Beretta L; Braga M
Clin Nutr; 2017 Dec; 36(6):1649-1653. PubMed ID: 27789123
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
